浙江 “浙”里春潮涌 “雨”后新绿生

Core Viewpoint - The Zhejiang Provincial Drug Administration is actively implementing the "Spring Rain Action" to enhance the transformation of clinical research results into medical device production, fostering innovation and collaboration across various departments and institutions [1][2]. Group 1: Organizational Structure and Mechanisms - The Zhejiang Provincial Drug Administration has established a dedicated working group for the "Spring Rain Action," ensuring effective organization and implementation through regular meetings and clear responsibilities [2]. - The agency has successfully added 19 new positions to the Zhejiang Medical Device Review Center, strengthening its core evaluation capabilities [2]. Group 2: Collaboration and Support - The Zhejiang Provincial Drug Administration is collaborating with the Provincial Health Commission to promote the "Spring Rain Action," including a province-wide medical device innovation competition [2]. - New regional testing and evaluation service centers have been established in various cities to provide localized support for clinical research result transformation [3]. Group 3: Policy Promotion and Training - The agency is conducting extensive policy promotion and training to ensure that the "Spring Rain Action" effectively reaches innovation entities, addressing common issues faced by medical institutions [4][5]. - Specialized training sessions have been organized to enhance the understanding of registration processes among clinical research teams [4]. Group 4: Project Selection and Resource Allocation - A rigorous project selection mechanism has been established to focus evaluation resources on high-value projects, categorizing 172 submitted projects into three tiers based on innovation and clinical value [6]. - Feedback and guidance are provided to projects deemed less viable, ensuring a targeted approach to resource allocation [6]. Group 5: Accelerating Transformation - The Zhejiang Provincial Drug Administration is optimizing review processes and enhancing collaboration with national agencies to expedite the transformation of clinical results into market-ready products [8][9]. - Several innovative medical devices have been rapidly approved for market entry, showcasing the effectiveness of the "Spring Rain Action" in facilitating clinical result transformation [9].